Researchers discovered a mechanism that stops the body reacting with an excessive immune reaction. This could be the basis for a new treatment.
Most people with allergies have to take medication throughout their life: Their body “thinks” that proteins from the environment are so “strange” that they elicit an immune reaction. Until present, it was not possible to develop an efficient therapy so that the body “learns” to stop in an overreacting way.
Scientists from the Swiss Institute of Allergy and Asthma Research (SIAF) in Davos, from the University of Tokyo, the RIKEN Research Institute in Yokohoma, and from Stanford University recently discovered a mechanism that could be the basis for a new way to handle allergies.
Mast cells play a key role in the disease process in allergies: As a reaction towards an allergen – for example pollen or dust mites – they release big amounts of substances that initiate an inflammatory process. Study leader Hideaki Morita and his team discovered that mast cells are not only “bad guys”, but also have a “good side” (see figure): They release the substance interleukin-2 that induces the production of certain immune cells called T-regulatory (Treg) cells. Treg cells can suppress the allergic inflammatory process in the airways induced by interleukin-10.
It is already known for some time that Treg cells can subdue an excessive immune response and the resulting inflammation. For example, injections with Treg cells prevented autoimmune diseases in mice. However, for Treg cell treatments one needs a large amount of these cells, which is not easy to realise. In the blood, there are just a few of them, and in vitro they are difficult to produce. Using mast cells, Treg cells could be easily produced in the laboratory in large quantities.
“The mechanism that we discovered, could be the basis for a new way to handle allergies,” says Hideaki Morita.
Read more: A possible cure for allergies
The Latest on: Cure for allergies
via Google News
The Latest on: Cure for allergies
- ALLERGIC RHINITIS: Is it that season of the year again?on June 27, 2020 at 5:59 pm
Seasons come and seasons go...” A change in seasons of the year might bring enjoyment of warmth, sunshine and brightness ...
- Risks for some drugs rise as temperatures climbon June 27, 2020 at 11:58 am
Summer is here and, along with it, the threat of heat waves and heat-related illness. Heat waves kill more people than any other single weather event, making them dangerous by themselves. But if you ...
- Risks for some medications rise as temperatures climbon June 27, 2020 at 9:09 am
We need to be mindful when medications mix with heat. Too much heat can make an otherwise safe and effective drug dangerous.” Some medicines, such as diuretics, make our bodies lose water, which can ...
- Global Eye Allergy Treatment Market 2020 Growth Factor, Top Key Players, Industry Share, Size, Trends, Drivers and Forecast to 2025on June 27, 2020 at 12:58 am
Final Report will add the analysis of the impact of COVID-19 on this industry” Global “Eye Allergy Treatment Market” report studies the market in-depth and provides an all-encompassing analysis of the ...
- How Regeneron’s CEO Raced Into Clinical Trials With a Drug Developed for Covid-19on June 26, 2020 at 6:30 pm
Some seasoned medicines have been repurposed quickly to treat Covid-19, but in June, Regeneron Pharmaceuticals became one of the first companies to enter clinical trials with a drug developed ...
- Allergy Treatment Market Size study with COVID-19 Impact, Share, Global Industry Analysis, Growth, Trends, Segmentation and Forecast to 2025on June 26, 2020 at 12:49 pm
Jun 26, 2020 (CDN Newswire via Comtex) -- Changsha, China, HongChun Research: Global Allergy Treatment Market | HongChun Research has published a report titled Allergy Treatment Market Report that ...
- AllerGenis Begins Testing Patient Samples for Peanut Allergy Using Proprietary Epitope Mapping Technologyon June 24, 2020 at 5:00 am
AllerGenis announces onset of operations at its food allergy testing facility and validation results available from preprint server.
- Allergic reactions due to incorrect food labeling spark calls for tighter regulationson June 23, 2020 at 5:51 am
Incorrect labeling of food products is causing too many allergic reactions and needs to be more tightly regulated, a University of Melbourne researcher says.
- Palatin Technologies Developing PL8177 As Treatment For COVID-19 - Quick Factson June 23, 2020 at 4:56 am
Biopharmaceutical company Palatin Technologies, Inc. (PTN) announced Tuesday that it is developing PL8177 as a treatment for patients with COVID-19, and having hypoxemic respiratory failure with or ...
- The hunt for COVID-19 treatment, vaccineson June 18, 2020 at 9:49 am
With hundreds of clinical trials under way, here is a run down of the major developments in the search for COVID-19 treatments and prevention. Cheap and widely available, dexamethasone is a steroid ...
via Bing News